Results 181 to 188 of about 22,017 (188)

Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study

International Journal of Neuropsychopharmacology, 2010
Catherine Datto, Hans Eriksson, Eriksson Hans   +2 more
exaly  

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

Acta Psychiatrica Scandinavica, 1997
exaly  

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆

Journal of Affective Disorders, 2011
Catherine Datto, Shane Raines, Hans Eriksson   +2 more
exaly  

Quetiapine, QTc interval prolongation, and torsade de pointes : a review of case reports

Therapeutic Advances in Psychopharmacology, 2014
Mehrul Hasnain, W Victor R Vieweg, Robert H Howland   +2 more
exaly  

Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics

British Journal of Clinical Pharmacology, 2006
Scott W Grimm, Neil M Richtand
exaly  

Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder

American Journal of Geriatric Psychiatry, 2013
Hans Eriksson, Catherine Datto
exaly  

Safety and tolerability of once‐daily extended release quetiapine fumarate in acute schizophrenia: pooled data from randomised, double‐blind, placebo‐controlled studies

Human Psychopharmacology, 2010
exaly  

Quetiapine

Reactions Weekly, 2005
openaire   +1 more source